November 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreOctober 01, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreNovember 12, 2025
Market insights predict, the North America in-vitro diagnostics industry is expected to grow from USD 51.4 billion in 2024 to USD 85.21 billion by 2034, driven by a CAGR of 5.23%. In 2024, reagents led North America's in-vitro diagnostics market. Services and homecare are set to grow fastest. Immunoassays dominated tech, while microbiology and onco...
November 10, 2025
Projections indicate that, cancer biomarkers industry is projected to rise from USD 38.62 billion in 2025 to USD 128 billion by 2035, reflecting a CAGR of 12.73% over the next decade. he advancement in technology and growing integration of AI in R&D and other aspects of oncology is increasing the growth of the market....
November 05, 2025
Market insights predict the global cellular health screening industry will increase from USD 3.37 billion in 2024 to USD 8.14 billion by 2034, achieving a CAGR of 9.24%. The rising prevalence of chronic disorders and technological advancements drive the global market. Whereas, the presence of a robust healthcare infrastructure and increasing invest...
November 05, 2025
Market insights predict, the breast cancer screening tests industry is expected to grow from USD 4.44 billion in 2024 to USD 8.77 billion by 2034, driven by a CAGR of 7.04%. The breast cancer screening tests market is growing due to its major applications, including mammography, breast ultrasound, breast MRI, clinical breast examination (CBE), brea...
November 01, 2025
According to market projections, the central lab sector is expected to grow from USD 3.46 billion in 2024 to USD 6.04 billion by 2034, reflecting a CAGR of 5.71%. The market is driven by increasing clinical trials, rising demand for precision medicine, advanced diagnostics, digital lab innovations, and growing pharmaceutical R&D activities....
November 01, 2025
Market insights predict, the central lab industry is expected to grow from USD 3.46 billion in 2024 to USD 6.04 billion by 2034, driven by a CAGR of 5.71%. A central lab is a specialized facility for conducting lab tests, mainly in clinical trials, to ensure consistent data from various sites. Using advanced equipment, technicians analyze blood, ur...
November 01, 2025
Market insights predict, the AI in cancer diagnostics industry is expected to grow from USD 1.07 billion in 2024 to USD 2.61 billion by 2034, driven by a CAGR of 9.35%. AI is revolutionizing cancer diagnostics by enhancing speed, accuracy, and efficiency. With rising cancer rates, demand for precision medicine, and advancements in AI, especially ma...
November 01, 2025
Market insights predict the global pancreatic cancer industry will increase from USD 2.65 billion in 2024 to USD 9.57 billion by 2034, achieving a CAGR of 13.7%. Pancreatic cancer is a deadly disease that starts in the pancreas, an organ that helps digest food and regulate blood sugar. It often grows silently, showing few symptoms until it spreads....
November 01, 2025
Based on market forecasts, the stroke diagnostics and therapeutics sector will expand from USD 38.03 billion in 2024 to USD 76.23 billion by 2034, experiencing a CAGR of 7.2%. Stroke diagnostics and therapeutics focus on quickly identifying and treating strokes to prevent brain damage and improve recovery. Advanced imaging, biomarkers, and AI help ...
November 01, 2025
Market insights predict the global hemato-oncology testing industry will increase from USD 3.56 billion in 2024 to USD 11.47 billion by 2034, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the top focus, making up 40% of the market. PCR technology dominated testing methods with a 45% share, ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com